Wagner Bowman Management Corp boosted its stake in Becton, Dickinson and Company (NYSE:BDX) by 5.5% during the second quarter, Holdings Channel reports. The fund owned 1,905 shares of the medical instruments supplier’s stock after buying an additional 100 shares during the period. Wagner Bowman Management Corp’s holdings in Becton, Dickinson and were worth $371,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BDX. North Star Investment Management Corp. boosted its position in shares of Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 18 shares during the last quarter. Crestwood Advisors Group LLC purchased a new position in shares of Becton, Dickinson and during the first quarter valued at about $101,000. Almanack Investment Partners LLC. purchased a new position in shares of Becton, Dickinson and during the first quarter valued at about $105,000. Parkside Financial Bank & Trust boosted its position in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares during the last quarter. Finally, Financial Architects Inc boosted its position in shares of Becton, Dickinson and by 62.7% in the first quarter. Financial Architects Inc now owns 677 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 261 shares during the last quarter. Hedge funds and other institutional investors own 75.71% of the company’s stock.

Shares of Becton, Dickinson and Company (BDX) traded up 0.02% during mid-day trading on Thursday, reaching $197.87. The company’s stock had a trading volume of 495,440 shares. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63. The company has a market capitalization of $45.03 billion, a price-to-earnings ratio of 57.30 and a beta of 1.05. The company’s 50 day moving average price is $198.62 and its 200-day moving average price is $187.41.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The firm’s revenue was down 5.1% compared to the same quarter last year. During the same period in the prior year, the business earned $2.35 EPS. Analysts predict that Becton, Dickinson and Company will post $9.45 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.48%. The ex-dividend date of this dividend is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio is presently 83.43%.

ILLEGAL ACTIVITY NOTICE: “Becton, Dickinson and Company (BDX) Shares Bought by Wagner Bowman Management Corp” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/10/becton-dickinson-and-company-bdx-shares-bought-by-wagner-bowman-management-corp.html.

BDX has been the subject of several recent research reports. BidaskClub cut Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Sunday. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday. Zacks Investment Research cut Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday. Cowen and Company reiterated an “outperform” rating and set a $230.00 price target (up from $200.00) on shares of Becton, Dickinson and in a research report on Monday, July 10th. Finally, Bank of America Corporation reiterated a “buy” rating and set a $225.00 price target (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Becton, Dickinson and has a consensus rating of “Buy” and a consensus price target of $194.69.

In other news, VP Jeffrey S. Sherman sold 28,765 shares of the stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the transaction, the vice president now directly owns 70,821 shares of the company’s stock, valued at approximately $13,171,289.58. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 1.40% of the stock is owned by corporate insiders.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.